BioPortUSA is pleased to announce the addition of two more subject matter experts to our team. Medical Device Academy is considered to be one of the top boutique FDA consultancies that also has a firm understanding of regulatory requirements from other countries around the world including CE and MDR marking. Mark Lesselroth, CEO of BioPortUSA said that “we are thrilled to have Rob Pakcard and his team on board not only because they can assist our international med-tech companies with 510K and De Novo applications but also because they have the ability to help our U.S. based clients with navigating the regulatory pathway in other parts of the world.”
In addition to Medical Device Academy, BioPortUSA welcomes Marc Sanchez and his firm FDA Atty. “Marc is considered to be one of the premier attorneys and FDA specialists in the U.S.A. when it comes to matters associated with cannabis.” FDA Atty will not only be focused on BioPortUSA clients who are operating in the cannabinoid space but also other firms whose products are viewed more as an ingredient or food. His expertise will no doubt also help other subject matter experts who are engaged with clients in the cannabinoid arena.